Evidence map›Paper›PMID 34437600›Full record

ArticlePloS one2021

A comparison of prediction approaches for identifying prodromal Parkinson disease.

Mark N Warden, Susan Searles Nielsen, Alejandra Camacho-Soto, Roman Garnett, Brad A Racette

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mark N WardenDepartment of Neurology, Washington University School of Medicine, Saint Louis, Missouri, United States of America.ORCID 0000-0002-1630-6018
Susan Searles NielsenDepartment of Neurology, Washington University School of Medicine, Saint Louis, Missouri, United States of America.
Alejandra Camacho-SotoDepartment of Neurology, Washington University School of Medicine, Saint Louis, Missouri, United States of America.
Roman GarnettDepartment of Computer Science and Engineering, Washington University in Saint Louis, Saint Louis, Missouri, United States of America.
Brad A RacetteDepartment of Neurology, Washington University School of Medicine, Saint Louis, Missouri, United States of America.ORCID 0000-0002-9582-8235
Washington University in St. Louis · USUniversity of the Witwatersrand · ZA

Funding

Epidemiology and Biomarkers of Parkinsonism in WeldersK24ES017765 · NIEHS · WASHINGTON UNIVERSITY · PI RACETTE, BRAD A · 2009 to 2018
$1.5M
A Nationwide Study of Environmental Risk Factors for Parkinson DiseaseK01ES028295 · NIEHS · WASHINGTON UNIVERSITY · PI SEARLES NIELSEN, SUSAN · 2018 to 2020
$450k
NIEHS NIH HHS K01 ES028295NIEHS NIH HHS K24 ES017765
6 · The paper itself

Abstract

Identifying people with Parkinson disease during the prodromal period, including via algorithms in administrative claims data, is an important research and clinical priority. We sought to improve upon an existing penalized logistic regression model, based on diagnosis and procedure codes, by adding prescription medication data or using machine learning. Using Medicare Part D beneficiaries age 66-90 from a population-based case-control study of incident Parkinson disease, we fit a penalized logistic regression both with and without Part D data. We also built a predictive algorithm using a random forest classifier for comparison. In a combined approach, we introduced the probability of Parkinson disease from the random forest, as a predictor in the penalized regression model. We calculated the receiver operator characteristic area under the curve (AUC) for each model. All models performed well, with AUCs ranging from 0.824 (simplest model) to 0.835 (combined approach). We conclude that medication data and random forests improve Parkinson disease prediction, but are not essential.

Indexed as

Prodromal SymptomsAgedAged, 80 and overCase-Control StudiesFemaleHumansMaleMedicareMiddle AgedModels, TheoreticalParkinson DiseaseProbabilityUnited States

Identifiers

PMID34437600
PMCPMC8389479
OpenAlexW3194899141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.